Nakase T, Tatewaki Y, Takano Y, Nomura S, Baek H, Taki Y
Int J Mol Sci. 2025; 26(5).
PMID: 40076944
PMC: 11899992.
DOI: 10.3390/ijms26052325.
Sarkar S, Porel P, Kosey S, Aran K
Inflammopharmacology. 2025; .
PMID: 40057929
DOI: 10.1007/s10787-025-01697-y.
Soltani S, Dolatshahi M, Soltani S, Khazaei K, Rahmani M, Raji C
Hum Brain Mapp. 2025; 46(4):e70180.
PMID: 40033766
PMC: 11876560.
DOI: 10.1002/hbm.70180.
Amiri F, Safiri S, Shamekh A, Ebrahimi A, Sullman M, Kolahi A
Sci Rep. 2025; 15(1):7058.
PMID: 40016362
PMC: 11868542.
DOI: 10.1038/s41598-025-89899-w.
Rullo M, La Spada G, Stefanachi A, Macchia E, Pisani L, Leonetti F
Molecules. 2025; 30(4).
PMID: 40005200
PMC: 11857976.
DOI: 10.3390/molecules30040891.
Critical role of Oas1g and STAT1 pathways in neuroinflammation: insights for Alzheimer's disease therapeutics.
Xie Z, Li L, Hou W, Fan Z, Zeng L, He L
J Transl Med. 2025; 23(1):182.
PMID: 39953505
PMC: 11829366.
DOI: 10.1186/s12967-025-06112-2.
Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases.
Grahl M, Hohl K, Smaniotto T, Carlini C
Molecules. 2025; 30(3).
PMID: 39942791
PMC: 11820544.
DOI: 10.3390/molecules30030687.
Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study.
Zuniga C, Acosta B, Menchaca R, Amescua C, Hong S, Hui L
Alzheimers Res Ther. 2025; 17(1):40.
PMID: 39939891
PMC: 11817217.
DOI: 10.1186/s13195-025-01681-2.
Multi-parametric [F]PI-2620 tau PET/MRI for the phenotyping of different Alzheimer's disease variants.
Rullmann M, Henssen D, Melasch J, Scherlach C, Saur D, Schroeter M
Eur J Nucl Med Mol Imaging. 2025; .
PMID: 39937274
DOI: 10.1007/s00259-025-07135-z.
RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer's disease mouse models.
Cho Y, Lee J, Kim J, Jeon Y, Han S, Cho H
Anim Cells Syst (Seoul). 2025; 29(1):122-134.
PMID: 39931645
PMC: 11809180.
DOI: 10.1080/19768354.2025.2459649.
Astrocytic EphA4 signaling is important for the elimination of excitatory synapses in Alzheimer's disease.
Yang X, Wang Y, Qiao Y, Lin J, Lau J, Fu W
Proc Natl Acad Sci U S A. 2025; 122(7):e2420324122.
PMID: 39928878
PMC: 11848297.
DOI: 10.1073/pnas.2420324122.
Clinical biomarkers of perioperative neurocognitive disorder: initiation and recommendation.
Liu J, Li C, Yao J, Zhang L, Zhao X, Lv X
Sci China Life Sci. 2025; .
PMID: 39918707
DOI: 10.1007/s11427-024-2797-x.
Novel multipotent conjugate bearing tacrine and donepezil motifs with dual cholinergic inhibition and neuroprotective properties targeting Alzheimer's disease.
Yepes A, Cardona-Galeano W, Herrera-Ramirez A, Rada M, Osorio E, Gonzalez-Molina L
RSC Med Chem. 2025; .
PMID: 39867586
PMC: 11756598.
DOI: 10.1039/d4md00804a.
Cell Adhesion Molecule Protocadherin-γC5 Ameliorates Aβ Plaque Pathogenesis by Modulating Astrocyte Function in Alzheimer's Disease.
Sun X, Pan S, Li D, Su M, Zheng H, Zhang Y
J Neurosci. 2025; 45(10).
PMID: 39843233
PMC: 11884392.
DOI: 10.1523/JNEUROSCI.0967-24.2025.
Genome-wide association neural networks identify genes linked to family history of Alzheimer's disease.
Ghose U, Sproviero W, Winchester L, Amin N, Zhu T, Newby D
Brief Bioinform. 2025; 26(1.
PMID: 39775791
PMC: 11707606.
DOI: 10.1093/bib/bbae704.
Irisin: A Multifaceted Hormone Bridging Exercise and Disease Pathophysiology.
Paoletti I, Coccurello R
Int J Mol Sci. 2025; 25(24.
PMID: 39769243
PMC: 11676223.
DOI: 10.3390/ijms252413480.
Deep Brain Stimulation Combined with NMDA Antagonist Therapy in the Treatment of Alzheimer's Disease: In Silico Trials.
Swietlik D
J Clin Med. 2025; 13(24.
PMID: 39768683
PMC: 11728097.
DOI: 10.3390/jcm13247759.
Pharmacogenomics for neurodegenerative disorders - a focused review.
Ahmad S, Zeyaullah M, Khan M, AlShahrani A, Altijani A, Ali H
Front Pharmacol. 2025; 15:1478964.
PMID: 39759457
PMC: 11695131.
DOI: 10.3389/fphar.2024.1478964.
Novel mouse model of Alzheimer's disease exhibits pathology through synergistic interactions among amyloid-β, tau, and reactive astrogliosis.
Han Y, Lim S, Lee S, Nam M, Oh S
Zool Res. 2025; 46(1):41-53.
PMID: 39757019
PMC: 11890996.
DOI: 10.24272/j.issn.2095-8137.2024.257.
A Novel RAGE Modulator Induces Soluble RAGE to Reduce BACE1 Expression in Alzheimer's Disease.
Baek S, Hong S, Kim E, Park S, Lee M, Park J
Adv Sci (Weinh). 2025; 12(8):e2407812.
PMID: 39755927
PMC: 11848596.
DOI: 10.1002/advs.202407812.
